Sabra Health Care REIT Analyst Ratings
Truist Adjusts Price Target on Sabra Health Care REIT to $16 From $15, Maintains Buy Rating
Sabra Health Care REIT Analyst Ratings
Scotiabank Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)
Sabra Health Care REIT Analyst Ratings
Sabra Health Care REIT Analyst Ratings
Scotiabank Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)
Stifel Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16
Sabra Health Care REIT Analyst Ratings
Sabra Health Care REIT Downgraded at BMO on Profit-taking Opportunity
BMO Capital Downgrades Sabra Health Care REIT to Market Perform, Announces $16 Price Target
Sabra Health Care REIT Analyst Ratings
Wells Fargo Upgrades Sabra Health Care REIT to Equal-Weight, Announces $15 Price Target
Sabra Health Care REIT Analyst Ratings
Analyst Ratings for Sabra Health Care REIT
Sabra Health Care REIT Analyst Ratings
Wedbush Initiates Coverage On Sabra Health Care REIT With Outperform Rating, Announces Price Target of $16
Sabra Health Care REIT Analyst Ratings
Jefferies Upgrades Sabra Health Care REIT to Buy, Raises Price Target to $15
Sabra Health Care REIT Analyst Ratings
No Data